Copyright (c) 2022 AJC
This work is licensed under a Creative Commons Attribution 4.0 International License.
An Efficient, Novel Synthetic Route to (R)-Salmeterol Xinafoate and Facile Synthetic Protocols for Preparation of its Process Related Potential Impurities
Corresponding Author(s) : Sathyanarayana Boodida
Asian Journal of Chemistry,
Vol. 34 No. 12 (2022): Vol 34 Issue 12, 2022
Abstract
In present work, an effective, innovative enantioselective synthetic strategy for the synthesis of salmeterol xinafoate and its probable process-related impurities was reported. Seven pharmacopeia specified impurities were synthesized and confirmed by FT-IR, mass, 1H & 13C NMR spectroscopy. With respect to the corresponding retention factors, these contaminants were validated using the available RP-HPLC method. These compounds can be used as a reference standard for the active pharmaceutical ingredient manufactures and research organizations.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- R.N. Brogden and D. Faulds, Drugs, 42, 895 (1991); https://doi.org/10.2165/00003495-199142050-00010
- D.I. Ball, R.T. Brittain, R.A. Coleman, L.H. Denyer, D. Jack, M. Johnson, L.H.C. Lunts, A.T. Nials, K.E. Sheldrick and I.F. Skidmore, Br. J. Pharmacol., 104, 665 (1991); https://doi.org/10.1111/j.1476-5381.1991.tb12486.x
- M. Johnson, P.R. Butchers, R.A. Coleman, A.T. Nials, P. Strong, M.J. Summer, C.J. Vardey and C.J. Whelan, Life Sci., 52, 2131 (1993); https://doi.org/10.1016/0024-3205(93)90728-L
- M. Johnson, Paediatr. Respir. Rev., 2, 57 (2001); https://doi.org/10.1053/prrv.2000.0102
- C.W. Bierman, J.P. Kemp and M.J. Sharpe, J. Allergy Clin. Immunol., 85, 198 (1990).
- A.A. Verberne, W.C. Hop, A.B. Bos and K.F. Kerrebijn, J. Allergy Clin. Immunol., 91, 127 (1993); https://doi.org/10.1016/0091-6749(93)90305-Y
- B. Lundback, D.W. Rawlinson and J.B. Palmer, Thorax, 48, 148 (1993).
- P. Wilding, J. Thompson-Coon J and M. Clark, Thorax, 50, A39 (1995).
- G.G. Meijer, D.S. Postma, P.G. Mulder and W.M. Van Aalderen, Am. J. Respir. Crit. Care Med., 152, 1887 (1995); https://doi.org/10.1164/ajrccm.152.6.8520751
- S.P. Newman, G. Woodman, S.W. Clarke and M.A. Sackner, Am. Rev. Respir. Dis., 131, A96 (1985).
- N.A. Hanania, P. Darken, D. Horstman, C. Reisner, B. Lee, S. Davis and T. Shah, Chest, 124, 834 (2003); https://doi.org/10.1378/chest.124.3.834
- N. Svedmyr and C.G. Lofdahl, Pharmacol. Toxicol., 78, 3 (1996); https://doi.org/10.1111/j.1600-0773.1996.tb00172.x
- G. Shapiro, W. Lumry, J. Wolfe, J. Given, M. White, A. Woodring, L. Baitinger, K. House, B. Prillaman and T. Shah, Am. J. Respir. Crit. Care Med., 161, 527 (2000); https://doi.org/10.1164/ajrccm.161.2.9905091
- J.J. Condemi, S. Goldstein, C. Kalberg, S. Yancey, A. Emmett and K. Rickard, Ann. Allergy Asthma Immunol., 82, 383 (1999); https://doi.org/10.1016/S1081-1206(10)63288-7
- W. Busse, S.M. Koenig, J. Oppenheimer, S.A. Sahn, S.W. Yancey, D. Reilly, L.D. Edwards and P.M. Dorinsky, J. Allergy Clin. Immunol., 111, 57 (2003); https://doi.org/10.1067/mai.2003.38
- N. Ringdal, A. Eliraz, R. Pruzinec, H.-H. Weber, P.G.H. Mulder, M. Akveld and E.D. Bateman, Respir. Med., 97, 234 (2003); https://doi.org/10.1053/rmed.2003.1436
- B. Davies, G. Brooks and M. Devoy, Respir. Med., 92, 256 (1998); https://doi.org/10.1016/S0954-6111(98)90105-6
- ICH Harmonized Tripartite Guideline, Impurities in New Drug Substances Q3A (R2), edn. 4 (2006).
- ICH Harmonized Tripartite Guideline, Impurities in New Drug Products Q3B (R2), edn. 4 (2006).
- USP Pharmacopeias Forum. Volume No. 35(2), Page 307. 21. S. Lemaire, I.N. Houpis, T. Xiao, J. Li, E. Digard, C. Gozlan, R. Liu, A. Gavryushin, C. Diène, Y. Wang, V. Farina and P. Knochel, Org. Lett., 14, 1480 (2012); https://doi.org/10.1021/ol300220p
- ICH Harmonized Triplicate Guideline: Impurities in New Drug Substances Q3A (R2), ICH Steering Committee, Step 4 of ICH process (2006).
- I.F. Skidmore, L.H.C. Lunts, H. Finch and A. Naylor, GB Patent 2140800 (1993).
- B.V. Bhaskar, E.R.C. Sekhar, B.S. Reddy, V.S.N.V. Lakshmi Varaprasad, P. Rajagopal, S.S. Reddy, C.P. Arulnathan, D. Surya and S. Reddy, Preparation of Salmeterol and salts there of, Swiss Patent, 2560/CHE/2008A (2008).
- S.D. Dwivedi, N. Shah and Shyamlal, Process for the Preparation of Salmeterol and its Intermediates, WO2012/032546 A2 (2012).
- R. Hett, R. Stare and P. Helquist, Tetrahedron Lett., 35, 9375 (1994); https://doi.org/10.1016/S0040-4039(00)78546-7
- Y. Rong and A.E. Ruoho, Synth. Commun., 29(12a), 2155 (1999); https://doi.org/10.1080/00397919908086211
- J. Liu, D. Zhou, X. Jia, L. Huang, X. Li and A.S.C. Chan, Tetrahedron Asymm., 19, 1824 (2008); https://doi.org/10.1016/j.tetasy.2008.07.021
- S. Hbaïeb, Z. Latin and H. Amri, Synth. Commun., 29, 981 (1999); https://doi.org/10.1080/00397919908086061
- G.W. Gribble, Chem. Soc. Rev., 27, 395 (1998); https://doi.org/10.1039/a827395z
- P.A. Procopiou, G.E. Morton, M. Todd and G. Webb, Tetrahedron Asymm., 12, 2005 (2001); https://doi.org/10.1016/S0957-4166(01)00350-0
- C.E. Clark, A.D. Ferguson and J.A. Siddorn, Respir. Med., 87, 227 (1993); https://doi.org/10.1016/0954-6111(93)90098-K
References
R.N. Brogden and D. Faulds, Drugs, 42, 895 (1991); https://doi.org/10.2165/00003495-199142050-00010
D.I. Ball, R.T. Brittain, R.A. Coleman, L.H. Denyer, D. Jack, M. Johnson, L.H.C. Lunts, A.T. Nials, K.E. Sheldrick and I.F. Skidmore, Br. J. Pharmacol., 104, 665 (1991); https://doi.org/10.1111/j.1476-5381.1991.tb12486.x
M. Johnson, P.R. Butchers, R.A. Coleman, A.T. Nials, P. Strong, M.J. Summer, C.J. Vardey and C.J. Whelan, Life Sci., 52, 2131 (1993); https://doi.org/10.1016/0024-3205(93)90728-L
M. Johnson, Paediatr. Respir. Rev., 2, 57 (2001); https://doi.org/10.1053/prrv.2000.0102
C.W. Bierman, J.P. Kemp and M.J. Sharpe, J. Allergy Clin. Immunol., 85, 198 (1990).
A.A. Verberne, W.C. Hop, A.B. Bos and K.F. Kerrebijn, J. Allergy Clin. Immunol., 91, 127 (1993); https://doi.org/10.1016/0091-6749(93)90305-Y
B. Lundback, D.W. Rawlinson and J.B. Palmer, Thorax, 48, 148 (1993).
P. Wilding, J. Thompson-Coon J and M. Clark, Thorax, 50, A39 (1995).
G.G. Meijer, D.S. Postma, P.G. Mulder and W.M. Van Aalderen, Am. J. Respir. Crit. Care Med., 152, 1887 (1995); https://doi.org/10.1164/ajrccm.152.6.8520751
S.P. Newman, G. Woodman, S.W. Clarke and M.A. Sackner, Am. Rev. Respir. Dis., 131, A96 (1985).
N.A. Hanania, P. Darken, D. Horstman, C. Reisner, B. Lee, S. Davis and T. Shah, Chest, 124, 834 (2003); https://doi.org/10.1378/chest.124.3.834
N. Svedmyr and C.G. Lofdahl, Pharmacol. Toxicol., 78, 3 (1996); https://doi.org/10.1111/j.1600-0773.1996.tb00172.x
G. Shapiro, W. Lumry, J. Wolfe, J. Given, M. White, A. Woodring, L. Baitinger, K. House, B. Prillaman and T. Shah, Am. J. Respir. Crit. Care Med., 161, 527 (2000); https://doi.org/10.1164/ajrccm.161.2.9905091
J.J. Condemi, S. Goldstein, C. Kalberg, S. Yancey, A. Emmett and K. Rickard, Ann. Allergy Asthma Immunol., 82, 383 (1999); https://doi.org/10.1016/S1081-1206(10)63288-7
W. Busse, S.M. Koenig, J. Oppenheimer, S.A. Sahn, S.W. Yancey, D. Reilly, L.D. Edwards and P.M. Dorinsky, J. Allergy Clin. Immunol., 111, 57 (2003); https://doi.org/10.1067/mai.2003.38
N. Ringdal, A. Eliraz, R. Pruzinec, H.-H. Weber, P.G.H. Mulder, M. Akveld and E.D. Bateman, Respir. Med., 97, 234 (2003); https://doi.org/10.1053/rmed.2003.1436
B. Davies, G. Brooks and M. Devoy, Respir. Med., 92, 256 (1998); https://doi.org/10.1016/S0954-6111(98)90105-6
ICH Harmonized Tripartite Guideline, Impurities in New Drug Substances Q3A (R2), edn. 4 (2006).
ICH Harmonized Tripartite Guideline, Impurities in New Drug Products Q3B (R2), edn. 4 (2006).
USP Pharmacopeias Forum. Volume No. 35(2), Page 307. 21. S. Lemaire, I.N. Houpis, T. Xiao, J. Li, E. Digard, C. Gozlan, R. Liu, A. Gavryushin, C. Diène, Y. Wang, V. Farina and P. Knochel, Org. Lett., 14, 1480 (2012); https://doi.org/10.1021/ol300220p
ICH Harmonized Triplicate Guideline: Impurities in New Drug Substances Q3A (R2), ICH Steering Committee, Step 4 of ICH process (2006).
I.F. Skidmore, L.H.C. Lunts, H. Finch and A. Naylor, GB Patent 2140800 (1993).
B.V. Bhaskar, E.R.C. Sekhar, B.S. Reddy, V.S.N.V. Lakshmi Varaprasad, P. Rajagopal, S.S. Reddy, C.P. Arulnathan, D. Surya and S. Reddy, Preparation of Salmeterol and salts there of, Swiss Patent, 2560/CHE/2008A (2008).
S.D. Dwivedi, N. Shah and Shyamlal, Process for the Preparation of Salmeterol and its Intermediates, WO2012/032546 A2 (2012).
R. Hett, R. Stare and P. Helquist, Tetrahedron Lett., 35, 9375 (1994); https://doi.org/10.1016/S0040-4039(00)78546-7
Y. Rong and A.E. Ruoho, Synth. Commun., 29(12a), 2155 (1999); https://doi.org/10.1080/00397919908086211
J. Liu, D. Zhou, X. Jia, L. Huang, X. Li and A.S.C. Chan, Tetrahedron Asymm., 19, 1824 (2008); https://doi.org/10.1016/j.tetasy.2008.07.021
S. Hbaïeb, Z. Latin and H. Amri, Synth. Commun., 29, 981 (1999); https://doi.org/10.1080/00397919908086061
G.W. Gribble, Chem. Soc. Rev., 27, 395 (1998); https://doi.org/10.1039/a827395z
P.A. Procopiou, G.E. Morton, M. Todd and G. Webb, Tetrahedron Asymm., 12, 2005 (2001); https://doi.org/10.1016/S0957-4166(01)00350-0
C.E. Clark, A.D. Ferguson and J.A. Siddorn, Respir. Med., 87, 227 (1993); https://doi.org/10.1016/0954-6111(93)90098-K